Chief Scientific Officer
Dr. Brunstein obtained his Ph.D. in Biochemistry from the University of British Columbia in 1997, working on the molecular biology of viruses. Since then he has has worked with credible organizations including UBC as a Clinical Assistant Professor and later became the Chief Scientific Officer at the Centre for Translational and Applied Genomics. Dr. Brunstein has primarily worked through the company he founded, PathoID, as a consultant on biotechnology, molecular biology, and clinically related topics including clinical trials, assay validation methods, and quality systems in regulated industries for industrial and clinical sites in the US, Canada, and China. Dr. Brunstein has a broad exposure to biochemical analytical and molecular methods, quality systems, application of ISO/Health Canada/FDA and similar regulatory frameworks, and project management. His recognitions include the UBC Department of Pathology 2010 Faculty Award for Excellence in Research and Discovery, and he has an extensive publication record including a widely read monthly serialized article “The Primer” on aspects of clinical molecular diagnostics, now in its third year of publication in Medical Laboratory Observer.